QuidelOrtho Corporation
QDEL
株式のランク
#9840
QuidelOrtho Corporation specializes in the creation and production of... QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.
株価
$12.84
最終同期: 2026-10-16
時価総額
$880.51M
変化（1日）
-7.69%
変化（1年）
-70.20%
国
US
取引 QuidelOrtho Corporation (QDEL)
カテゴリー
Healthcare
の時価総額 QuidelOrtho Corporation(QDEL)
時価総額: $880.51M
October 2026時点で、QuidelOrtho Corporation の時価総額は $880.51M です。これは、当社のデータによると、QuidelOrtho Corporation が世界で9840th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
QuidelOrtho Corporation の時価総額の履歴（2022 から 2026 まで）
